SNA Insider Filing: Option Exercise Sale of 125 Shares and 10b5-1 Transaction

Rhea-AI Filing Summary

Form 144 filed for Snap-on Incorporated (SNA) discloses a proposed sale of 125 shares of common stock through Morgan Stanley Smith Barney on the NYSE, with an aggregate market value of $40,590.00 and approximately 52,163,371 shares outstanding. The filer reports those 125 shares were acquired on 08/15/2025 by exercise of stock options and paid for in cash on the same date.

The filing also lists a recent separate sale under a 10b5-1 plan: 4,731 shares sold on 08/14/2025 by Aldo Pagliari, producing gross proceeds of $1,548,850.87. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information and references Rule 10b5-1 where applicable.

Positive

• Disclosure is specific: acquisition date, exercise method, payment, broker, share counts, and aggregate value are provided
• 10b5-1 sale identified: recent 4,731-share sale reported with gross proceeds of $1,548,850.87, indicating planned, prearranged selling

Negative

• Limited information: filing contains only securities sale details and does not disclose any company operational or financial metrics
• Small sample of insider activity: the proposed sale (125 shares) is immaterial relative to total outstanding shares (52,163,371), offering little signal on insider views

Insights

Securities Analyst

TL;DR: Small, routine executive sale following option exercise; recent 10b5-1 sale generated material proceeds but may be routine selling.

The filing shows a proposed market sale of 125 shares acquired by option exercise the same day, indicating a routine disposition rather than a secondary issuance. The accompanying 10b5-1 sale of 4,731 shares on 08/14/2025 with gross proceeds of $1,548,850.87 is larger in economic impact and is explicitly identified as executed under a prearranged plan. For investors, the direct material metrics in this filing are the share counts and proceeds; there is no additional operational or financial data disclosed here that would affect the company’s fundamentals.

Corporate Governance Expert

TL;DR: Disclosure aligns with Rule 144 and 10b5-1 procedures; no governance red flags visible in the notice.

The document supplies required details: acquisition method (option exercise), payment in cash, broker identity, and representation about material nonpublic information. The presence of an identified 10b5-1 sale for Aldo Pagliari provides transparency about planned insider selling. Absent any contradictory statements or omitted required fields in the provided text, the filing appears procedurally compliant. The impact on shareholder control or governance is negligible given the small size of the proposed sale relative to outstanding shares.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	125	40590.00	52163371	08/15/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/15/2025	Exercise of Stock Options	Issuer			125	08/15/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales Plan for ALDO PAGLIARI 2801 80th Street Kenosha WI 53143	Common	08/14/2025	4731	1548850.87

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for SNA disclose?

The form discloses a proposed sale of 125 common shares on 08/15/2025 via Morgan Stanley Smith Barney with aggregate market value $40,590.00; it also reports a 10b5-1 sale of 4,731 shares on 08/14/2025 with gross proceeds of $1,548,850.87.

How were the 125 shares acquired?

The 125 shares were acquired on 08/15/2025 by exercise of stock options and paid for in cash on that date.

Which broker is handling the proposed sale?

The broker named is Morgan Stanley Smith Barney LLC Executive Financial Services located at 1 New York Plaza, New York, NY; the sale is to occur on the NYSE.

Does this filing indicate undisclosed material information?

By signing the notice, the seller represents they do not know any material adverse information about the issuer that has not been publicly disclosed.

How large is the proposed sale relative to shares outstanding?

The proposed sale of 125 shares is small versus the reported outstanding shares of 52,163,371.